Anson Funds Management LP is 10% Owner at MEI Pharma, Inc. (MEIP). They have made 1 open-market trade across 1 company since 2016, most recently 2023-10-11.
CIK 0001491072
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $6.2M since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SCOO | BUY | 2016-11-22 | 2016-11-25 | $87.00 | $6.2M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.